Alpha-1 antitrypsin deficiency Augmentation Therapy Market: 2020 Growth, Size, Demand and Forecasts to 2026


Posted October 6, 2020 by Diya36821

The estimated rise in market value from its 2017 value of US$ 1115.5 Mn implies that the market will exhibit a CAGR of 5.9% in the foreacast period.
 
The estimated rise in market value from its 2017 value of US$ 1115.5 Mn implies that the market will exhibit a CAGR of 5.9% in the foreacast period. Fortune Business Insights expects that factors such as regulatory approvals and improvements in augmentation therapies will drive the market in this period. The Global AATD (Alpha-1 Antitrypsin Deficiency) Augmentation Therapy Market has been supported by late FDA endorsement for Prolastin-C. According to a report published by Fortune Business Insights, titled “AATD Augmentation Therapy: Global Analysis, Insights and Forecast, 2019-2026”, the market will be valued at US$ 1959.8 Mn by the end of 2026.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/aatd-augmentation-therapy-market-100169

Grifols SA’s AlfaCare Program Has Had a Positive Impact on the Global Market

In November 2018, Grifols Sa introduced AlfaCare, a therapy program aimed at providing training and counselling to AATD (Alpha-1 Antitrypsin Deficiency) Augmentation Therapy Market patients diagnosed with AATD. Grifols stated that with AlfaCare, it aims to encourage new habits in patients and help them manage their disease properly. Research studies have proven that a huge percentage of people diagnosed with AATD were unaware about the symptoms, effects, and ways to treat the disorder. AlfaCare was launched to overcome all such shortcomings and improve the quality of patient care, thereby ascertaining reduced fatality rate of AATD. Thus, AlfaCare has transformed AATD augmentation therapies worldwide and is likely to boost the global AATD augmentation therapy market in the forecast period.

KEY PLAYERS COVERED

Some of the major companies that are present in the Global Alpha-1 Antitrypsin Deficiency Therapy Market are;

Grifols S.A.
CSL Limited
Baxter
Kamada Ltd.
Takeda Pharmaceutical Company Limited
Abeona Therapeutics Inc., and other players.
North America to Dominate the Global Market

The growth in global alpha-1 antitrypsin deficiency treatment market is being driven by the emerging guideline for the treatment and diagnosis of alpha-1 antitrypsin deficiency treatment, potential pipeline products and rising awareness of alpha-1 antitrypsin deficiency. Furthermore, the rising prevalence of alpha-1 antitrypsin deficiency is expected to boost the global alpha-1 antitrypsin deficiency treatment market in the forecast period.

Segmentation:

By Distribution Channel

Hospital Pharmacy
Retail Pharmacy
Online Stores
By Route of Administration

Oral
Injection
Inhalation
By Drug Class

Alpha-1 proteinase inhibitor
Bronchodilators
Steroids
Antibiotics
New Biological Approval for Prolastin C to Enable Growth of Global Market

In September 2017, Grifols received biologics license approval for Alpha-1 Proteinase Inhibitor to add a new liquid formulation to the currently licensed Prolastin C. The inclusion of this liquid may enable the launch of an additional alternative to the existing therapy. Clinical trials and proven efficacy have favored the approval for this product. With the latest addition to its product portfolio, Grifols will increase its stronghold in the global AATD augmentation therapy market.

Request a Sample Copy of the Global Alpha-1 antitrypsin deficiency Augmentation Therapy Market Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/aatd-augmentation-therapy-market-100169

KEY QUESTIONS ANSWERED:

What is the market size and growth rate of the global and regional market by various segments?
What is the market size and growth rate of the market for selective countries?
Which region or sub-segment is expected to drive the market in the forecast period?
What Factors are estimated to drive and restrain the market growth?
What are the key technological and market trends shaping the market?
What are the key opportunities in the market?
What are the key companies operating in the market?
Which company accounted for the highest market share?
Why Choose Fortune Business Insights?
Related Reports:

Biliary Stent Market 2020 | Worldwide Growth, Global Share, Global Industry Analysis, Oulook, Supply, Development Status Forecast to 2026

Prostate Stents Market by 2026 Type Segment, Industry Segment, Market Dynamics, Market Size, Types and Applications

Portable Imaging Solutions Market by 2026 | Type Segment, Industry Analysis, Market Dynamics, Market Size, Types and Applications

About Us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune - 411045, Maharashtra, India.

Phone:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email: [email protected]
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Fortune Business Insights Pvt. Ltd.
Phone 4242530390
Business Address Fortune Business Insights™ Pvt. Ltd. 308, Supreme Headquarters,
Country India
Categories Advertising , Blogging , Blockchain
Tags alpha1 antitrypsin deficiency augmentation therapy market , alpha1 antitrypsin deficiency augmentation therapy market share , alpha1 antitrypsin deficiency augmentation therapy market size
Last Updated October 6, 2020